Clin Diabetes (2014) 32:3243
Research shows that: You may find that the side effects of semaglutide appear at different times of the day, such as when youve eaten or after taking your weekly dose
Current problems with the pancreas or kidneys
The newly approved oral GLP-1 orforglipron (Foundayo) is a distinct non-peptide small molecule with its own independent patent timeline.
This comparison breaks down how they differ for menopause, PCOS, hormonal health, weight loss, insurance, pricing, and ongoing provider support
What this article can do is make the framework clearer: if you are on Ozempic and it is working for you with tolerable side effects, the case for switching is weaker than if it is not working or the side effects are degrading your quality of life